Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-05 2:38 pm Sale | 13D | LIQUIDIA CORPORATION COM LQDA | New Enterprise Associates 12 Limited Partnership | 0 0% | -2,525,572 (Position Closed) | View |
| 2021-12-29 5:30 pm Sale | 13D | ARDELYX INC ARDX | New Enterprise Associates 12 Limited Partnership | 0 0% | -13,656,482 (Position Closed) | View |
| 2021-03-10 9:40 pm Unchanged | 13D | VIRACTA THERAPEUTICS INC VIRX | New Enterprise Associates 12 Limited Partnership | 0 0% | 0 (Unchanged) | View |
| 2021-03-10 9:39 pm Sale | 13D | TREVENA INC TRVN | New Enterprise Associates 12 Limited Partnership | 0 0% | -4,811,691 (Position Closed) | View |
| 2020-07-07 4:27 pm Unchanged | 13D | LIQUIDIA CORPORATION COM LQDA | New Enterprise Associates 12 Limited Partnership | 2,525,572 6.7% | 0 (Unchanged) | View |
| 2020-06-18 4:59 pm Sale | 13D | ARDELYX INC ARDX | New Enterprise Associates 12 Limited Partnership | 13,656,482 15.3% | -3,079,562 (-18.40%) | View |
| 2019-12-06 1:02 pm Sale | 13D | PROTEOSTASIS THERAPEUTICS INC PTI | New Enterprise Associates 12 Limited Partnership | 0 0% | -5,634,037 (Position Closed) | View |